Top compounds associated with response to RP11-219A15.1


Feature Type Standardized
Nominal ANOVA
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.031 0.4
mRNA itraconazole CTRPv2 pan-cancer AAC -0.03 0.4
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.027 0.4
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC -0.057 0.4
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.044 0.4
mRNA KU-55933 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.026 0.4
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC -0.024 0.4
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.029 0.4
Download CSV